NEWS
SentryX closes €3.2M seed funding round for the development of next generation pain relief therapeutics10/06/2021 - 09:55
TargED Biopharmaceuticals appoints Ludo Haazen, M.D. as Chief Medical Officer03/06/2021 - 16:48
NTrans Technologies closes Series A investment to accelerate development of gene editing therapy28/05/2021 - 10:39
